»óǰ ¾È³» ¹× ȯºÒ, ±³È¯, ¹è¼Û¹®ÀÇ | |
- °¡°Ô ÀüȹøÈ£ : | 1544-1900 |
- Àüȹ®ÀÇ ½Ã°£ : |
¿ÀÀü 9½ÃºÎÅÍ ¿ÀÈÄ 6½Ã±îÁö (¸ÅÁÖ ¿ù¿äÀÏ, È¿äÀÏ, ¼ö¿äÀÏ, ¸ñ¿äÀÏ, ±Ý¿äÀÏ, °øÈÞÀÏ Á¦¿Ü) |
- °¡°Ô À̸ÞÀÏ : | ink@kyobobook.co.kr |
- ÀÌ¿ë Åùèȸ»ç : | CJ´ëÇÑÅë¿î |
ÆÇ¸Å°¡°ÔÁ¤º¸ |
|
- »ç¾÷ÀÚ¸í : | (ÁÖ)±³º¸¹®°í |
- »ç¾÷ÀÚµî·Ï¹øÈ£ : | 102-81-11670 |
- Åë½ÅÆÇ¸Å¾÷½Å°í : | 01-0653 |
- Çö±Ý¿µ¼öÁõ : ¹ß±Þ°¡´É |
|
ÀüÈÁÖ¹® ¹× °áÁ¦¹®ÀÇ |
|
- ²ÉÇÇ´Â ¾ÆÄ§¸¶À» : | 1644-8422 |
°¡°Ô¿Í Á÷°Å·¡¸¦ ÇÏ½Ã¸é ²É¼ÛÀÌ Àû¸³ ¹× °¢Á¾ ÇýÅÿ¡¼ Á¦¿ÜµÇ°í, ¸¸ÀÏÀÇ ¹®Á¦°¡ ¹ß»ýÇÏ´Â °æ¿ì¿¡µµ ²É¸¶ÀÇ µµ¿òÀ» ¹ÞÀ¸½Ç ¼ö ¾ø½À´Ï´Ù. °¡°ÔÀÇ ºÎ´çÇÑ ¿ä±¸, ºÒ°øÁ¤ ÇàÀ§ µî¿¡ ´ëÇØ¼µµ ²É¸¶·Î Á÷Á¢ ÀüÈÁÖ¼¼¿ä. |
»ó¼¼Á¤º¸ | ±¸¸ÅÈıâ (0) | »óǰ Q&A (0) | ¹è¼Û/±³È¯/ȯºÒ ¾È³» |
Ã¥¼Ò°³À¯¹æ »ý°ËÀÇ Ãֽбâ¹ýÀ» ´Ù¾çÇÑ »çÁø°ú °ü·Ã ÀÚ·á·Î Àϸñ¿ä¿¬ÇÏ°Ô Á¤¸®ÇÑ Ã¥.
¸ñÂ÷1 Senologic ¼Ò°ßÀÇ ¹®¼È¿Í »ó°ü¼º Documentation and Correlation of Senologic Findings
Renzo Brun del Re
1.1 µµÀÔ Introduction
1.2 Senometry
1.2.1 Áغñ¹° Material
1.3 ÀÓ»ó ¼Ò°ß Ç¥½ÃÇϱâ Mapping Clinical Findings
1.4 2 cm º¸´Ù ÀÛÀº À¯¹æ º´º¯ À§Ä¡ Ç¥½ÃÇϱâ Mapping Mammographic Lesions Smaller than 2 cm
1.4.1 À¯¹æÃÔ¿µ»ó¿¡ ³ªÅ¸³ º´º¯¿¡ ´ëÇÑ À§Ä¡ Ç¥½Ã Mapping the Lesion on the Mammogram
1.4.2 À¯¹æÃÔ¿µ»óÀÇ ¼öÄ¡¸¦ À¯¹æ À§·Î ¿Å±â±â Transferring the Mammographic Dimensions onto the Breast
1.5 ¼ö¼ú ÁßÀÇ senometry¸¦ ÀÌ¿ëÇÑ Ä§ À§Ä¡ °áÁ¤¹ý Intraoperative Senometric Needle Localization
15
1.6 2 cm º¸´Ù Å« À¯¹æÃÔ¿µ»óÀÇ À¯¹æº´º¯ÀÇ µµ½ÄÈ Mapping Mammographic Lesions Larger than 2 cm
1.6.1 À¯¹æÃÔ¿µ»ó ³ªÅ¸³ º´º¯ À§Ä¡ÆÄ¾ÇÇϱâ Mapping the Lesion on the Mammogram
1.6.2 ÃøÁ¤µÈ ¼öÄ¡¸¦ À¯¹æ À§·Î ¿Å±â±â Transferring Dimensions onto the Breast
1.7 ÃÊÀ½ÆÄ»ó È®ÀÎµÈ ºñ ÃËÁö¼º º´º¯ Nonpalpable Lesion Detected by Ultrasound
1.8 SenometryÀÇ ÀÌÁ¡ Advantages of Senometry
References
2 ´ë±¸°æ Áø°øº¸Á¶ À¯¹æ »ý°Ë°ú ÀýÁ¦ »ý°ËÀÇ ºñ±³
Comparison of Large-Core Vacuum-Assisted Breast Biopsy and Excision Systems
Robin Wilson and Sanjay Kavia
2.1 ¼·Ð Introduction
2.2 ´ë±¸°æ Á᫐ »ý°Ë ½Ã½ºÅÛ : °³°ü Large-Core Biopsy Systems: Overview
2.2.1 ´ÜÀÏ ´ë±¸°æ-Á᫐ »ý°Ë ½Ã½ºÅÛ Single Large-Core Biopsy System
2.2.2 Áø°ø-º¸Á¶ À¯¹æ »ý°Ë ½Ã½ºÅÛ Vacuum-Assisted Mammotomy Systems
2.3 ÀûÀÀ°ú ÇѰè Indications and Limitations
2.3.1 ÇѰèÁ¡ Limitations
2.3.2 Áø´ÜÀû »ý°Ë Diagnostic Biopsy
2.3.3 Ä¡·áÀû ÀýÁ¦¼ú Therapeutic Excision
2.3.4 À̹ÌÁö À¯µµÇÏ »ý°Ë ±â¼ú Image-Guided Biopsy Technique
2.4 °á·Ð Conclusions
References
3 ÇÚµå Çïµå ¸¾¸ðÅèÀ» ÀÌ¿ëÇÑ ÃÊÀ½ÆÄ À¯µµÇÏ Áø°ø º¸Á¶ À¯¹æ »ý°Ë¼ú
Sonographically Guided Vacuum-Assisted Breast Biopsy Using Handheld Mammotome
Luc Steyaert, Filip Van Kerkhove, and Jan W. Casselman
3.1 ¼·Ð Introduction
3.2 Àåºñ Equipment
3.3 񃬣 Technique
3.4 ÀûÀÀÁõ Indications
3.4.1 ¾ç¼º ÀÇ½É È¤Àº ºÒÈ®½ÇÇÑ °áÀý¼º º´º¯ Probably Benign or Indeterminate Nodular Lesions
3.4.2 ¸Å¿ì ÀÛÀº Å©±âÀÇ ÀÇ½É º´º¯µé Very Small Suspicious Lesions
3.4.3 ±¹¼Ò °¨¼è ºÎºÐ Areas of Localized Attenuation
3.4.4 µ¶¸³µÈ, º¹ÇÕ ¼¶À¯ ³¶Á¾¼º ºÎºÐµé Isolated, Complex Fibrocystic Areas
3.4.5 À¯µÎÁ¾ Papillomas
3.4.6 ±ºÁý¼º ¹Ì¼¼¼®È¸È Clusters of Microcalcifications
3.4.7 ¾î·Á¿î À§Ä¡¿¡ ÀÖ´Â º´º¯µé Lesions in Difficult Locations
3.4.8 ÀÌÀü »ý°Ë ¶Ç´Â FNAC »ó ºñ °áÁ¤ÀûÀÎ ¸Å¿ì ´Ü´ÜÇÑ º´º¯µé
Very Hard Lesions with Inconclusive Previous Biopsy or FNAC
3.4.9 ºÒÃæºÐÇÑ FNAC ¶Ç´Â ¹Ì¼¼»ý°Ë °á°ú Inadequate FNAC or Microbiopsy Results
3.4.10 ¾ç¼º º´º¯ÀÇ Á¦°Å Removal of Benign Lesions
3.4.11 ³íÀÇµÈ ÀûÀÀÁõµé : ¹æ»ç»ó ¹ÝÈç, Å« ³¶Á¾ ³» º´º¯µé
Indications Discussed: Radial Scar, Large Intracystic Lesions
3.4.12 ´Ù¸¥ ÀûÀÀÁõµé Other Indications
3.5 Á᫐ °Ëü ó¸®Çϱâ Processing the Cores
3.6 ŽħÀÇ ±½±â Needle Size
3.7 Ŭ¸³ À§Ä¡½Ã۱â Clip Placement
3.8 ÃÊÀ½ÆÄ À¯µµ Vs À¯¹æÃÔ¿µ»ó À¯µµ US Versus Mammographic Guidance
3.9 °á°ú Results
References
4 Vacora »ý°Ë ½Ã½ºÅÛ TheVacora Biopsy System
R. Schulz-Wendtland
4.1 µµÀÔ Introduction
4.2 񃬣 Technique
4.3 ÀûÀÀÁõ°ú ±Ý±â»çÇ× Indications and Contraindications
4.3.1 ÃÊÀ½ÆÄ À¯µµÇÏ °æÇÇÀû Áø°ø »ý°Ë US-Guided Transcutaneous Vacuum Biopsy
4.3.2 Á¤À§Àû Áø°ø »ý°Ë Stereotactic Vacuum Biopsy
4.3.3 MRI À¯µµÇÏ Áø°ø »ý°Ë MRI-Guided Vacuum Biopsy
4.4 ºÎÀÛ¿ë Side Effects
4.5 °á°ú Results
4.6 ÇѰè Limitations
4.7 ½Ç¿ëÀûÀÎ ÈùÆ® Practical Hints
References
5 Á¤À§Àû À¯¹æ »ý°Ë Available Stereotactic Systems for Breast Biopsy
Ossi R. K?hli
5.1 µµÀÔ Introduction
5.1.1 ¾þµå¸° ÀÚ¼¼ ¹æ½Ä Prone Position Techniques
5.1.2 ¼öÁ÷ ½Ã½ºÅÛ Upright Systems
5.2 ½Ã½ºÅÛÀÇ ºñ¿ë Cost of the Systems
5.3 ½Ã¼úÀÇ ºñ¿ë Cost of the Procedures
References
6 MRI À¯µµÇÏ ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°Ë MRI-Guided Minimally Invasive Breast Procedures
Harald Marcel Bonel
6.1 µµÀÔ : MR ¸¾¸ð±×·¡ÇÇÀÇ ¿ªÇÒ Introduction: Role of MR Mammography
6.1.1 ÀûÀÀÁõ Indications
6.1.2 ±â¼ú°ú ½ÇÁ¦ÀûÀÎ ÆÁ Technique and Practical Tips
6.1.3 ÇѰè Limitations
6.2 °á·Ð Conclusion
References
7 À¯°ü³» Á¾¾ç¿¡ ´ëÇÑ À¯°ü³»½Ã°æ Ductoscopy of Intraductal Neoplasia of the Breast
Michael H?erbein, Matthias Raubach, Y.Y. Dai, and Peter M. Schlag
7.1 µµÀÔ Introduction
7.2 À¯°ü³» À¯¹æ ¼¼Æ÷¸¦ äÃëÇϱâ À§ÇÑ ¹æ¹ý Methods for Sampling Intraductal Breast Cells
7.2.1 À¯°ü³»½Ã°æ ±â¼ú Technique of Ductoscopy
7.2.2 À¯°ü³»½Ã°æ »ý°Ë Ductoscopic Biopsy
7.2.3 À¯µÎ ºÐºñ¹°ÀÌ ÀÖ´Â ¿©¼º¿¡¼ÀÇ À¯°ü³»½Ã°æ Ductoscopy in Women with Nipple Discharge
7.2.4 À¯¹æ¾Ï¿¡¼ÀÇ À¯°ü³»½Ã°æ Ductoscopy in Breast Cancer
7.3 ¿ä¾à Summary
References
8 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°Ë Á¶Á÷ÀÇ º´¸®
Pathology of Breast Tissue Obtained in Minimally Invasive Biopsy Procedures
Gad Singer and Sylvia Stadlmann
8.1 µµÀÔ Introduction
8.2 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°Ë Á¶Á÷ÀÇ º´¸® Pathology of Breast Disease in Minimally Invasive Biopsies
8.3 ¾ç¼º »óÇÇÁúȯ Benign Epithelial Lesions
8.3.1 °üÁÖÀ§ À¯¹æ¿° Periductal Mastitis
8.3.2 ¼¶À¯³¶Á¾¼º º¯È Fibrocystic Change
8.3.3 °æÈ¼º ¼±Áõ Sclerosing Adenosis
8.3.4 ¿øÁÖ¼¼Æ÷ º´º¯ Columnar Cell Lesions
8.3.5 º¸ÅëÀÇ »óÇÇ Áõ½Ä Usual-Type Epithelial Hyperplasia
8.3.6 ¼Ò¿±¼º Á¾¾ç Lobular Neoplasia
8.4 ¼¶À¯»óÇǼº º´º¯ Fibroepithelial Lesions
8.4.1 ¼¶À¯¼±Á¾ Fibroadenoma
8.4.2 ¿±»ó Á¾¾ç Phyllodes Tumor
8.4.3 ¾ç¼º À¯µÎ»ó º´º¯ Benign Papillary Lesions
8.5 ºñħÀ±¼º ¾Ï Malignant Noninvasive Lesions
8.6 ħÀ±¼º ¾Ï Invasive Carcinoma
8.7 À¯¹æ¾ÏÀÇ µî±Þ °áÁ¤ Grading of Breast Carcinoma
8.8 ÃÖ¼Ò Ä§½ÀÀû »ý°Ë¿¡¼ÀÇ ¿¹Ãø ÀÎÀÚ Predictive Factors in MIBS
References
9 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°ËÀÇ ÇѰè Limitations of Minimally Invasive Breast Biopsy
Mathias K. Fehr
9.1 ±â¼úÀûÀÎ ½ÇÆÐ Technical Failures
9.2 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°Ë¿¡¼ À¯¹æ º´¸®ÀÇ °ú¼ÒÆò°¡
Underestimation of Breast Pathology on Minimally Invasive Breast Biopsy Specimens
References
10 À¯¹æ ¿µ»óÀÇ ¹ßÀü: µô·¹¸¶ ȤÀº Áøº¸? Advances in Breast Imaging: A Dilemma or Progress?
Daniel Fl?y, Michael W. Fuchsjaeger, Christian F. Weisman, and Thomas H. Helbich
10.1 µµÀÔ Introduction
10.2 ÃÊÀ½ÆÄ Ultrasound
10.2.1 ´Ù¸é Ç¥½Ã ¸ðµå Multiplanar Display Mode
10.2.2 ÇÔ¿ä ¸ðµå ¿µ»ó Niche Mode View
10.2.3 Ç¥¸é ¸ðµå Surface Mode
10.2.4 Åõ¸í ¸ðµå Transparency Mode
10.2.5 Á¤Àû 3Â÷¿ø ¿ëÀû ´ëÁ¶¿µ»ó Static 3D Volume Contrast Imaging
10.2.6 4Â÷¿ø ¿ëÀû ´ëÁ¶µµ¿µ»ó 4D Volume Contrast Imaging
10.2.7 ¿ªÀü ¸ðµå Inversion Mode
10.2.8 ¿ëÀû °è»ê Volume Calculation
10.2.9 ´ÜÃþ ÃÊÀ½ÆÄ ¿µ»ó Tomographic Ultrasound Imaging
10.2.10 À¯¸®Ã¼ ·»´õ¸µ Glass Body Rendering
10.2.11 °È µµÇ÷¯, »öä µµÇ÷¯, ±×¸®°í °í¼±¸íµµ È帧
Power Doppler, Color Doppler, and High-Definition Flow
10.2.12 ¿¬ÀåµÈ ½Ã¾ß ±â·Ï Extended View Documentation
10.2.13 °á·Ð Conclusion
10.3 Àڱ⠰ø¸í ¿µ»ó Magnetic Resonance Imaging (MRI)
10.3.1 1.5-Å×½½¶ó ½Ã½ºÅÛ°ú Gadopentate 1.5-Tesla Systems and Gadopentetate
10.3.2 3.0-Å×½½¶ó ½Ã½ºÅÛ 3.0-Tesla Systems
10.3.3 °íºÐÀÚ Á¶¿µÁ¦ Macromolecular Contrast Agents
10.3.4 Á¾¾çƯÀÌ Á¶¿µÁ¦ Tumor-Specific Contrast Agents
10.3.5 ±â´ÉÀû À¯¹æ ¿µ»ó ±â¹ý (ºÐ±¤¹ý, È®»ê°Á¶¿µ»ó)
Functional Breast Imaging Techniques (Spectroscopy, Diffusion-Weighted Imaging)
10.4 ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ Positron Emission Tomography
10.4.1 ¼¼Æ÷ Áõ½Ä°ú ¼¼Æ÷ÀÚ¸ê»çÀÇ ¿µ»ó Imaging of Cellular Proliferation andApoptosis
10.4.2 ¼ö¿ëü ¿µ»ó Receptor Imaging
10.5 ±¤ÇÐ ¿µ»ó Optical Imaging
10.5.1 Çì¸ð±Û·Îºó ¿µ»ó Imaging of Hemoglobin
10.5.2 CTLM ÀåÄ¡ CTLM Device
10.5.3 ¿ÜÀμº Á¶¿µÁ¦ÀÇ ±¤ÇÐ ¿µ»ó Optical Imaging of Extrinsic Contrast Agents
10.6 Electrical Impedance Scanning
10.6.1 Ç¥Àû EIS¿Í TransScan TS2000 Targeted EIS with TransScanTS2000
10.6.2 T-Scan 2000ED¿Í Screening EIS
10.7 °á·Ð Conclusion
References
11 ºñ¿ë-È¿°ú ºÐ¼® Cost-Benefit Analyses
Renzo Brun del Re and Regula E. Burki
11.1 µµÀÔ Introduction
11.2 À¯¹æÃÔ¿µ¼úÀÇ ºóµµ Frequency of Mammography
11.3 ¼Òȯ·ü Recall Rate
11.3.1 ¼±º° °Ë»ç¿¡¼ÀÇ ¼ÒȯÀ² Recall Rate in Screening Programs
11.3.2 ¼±º° ÇÁ·Î±×·¥ ¿ÜÀÇ ¼ÒȯÀ² Recall Rate Outside of Screening Programs
11.4 Ãß°¡ °Ë»çÀÇ ºÐÆ÷ Distribution of Further Investigations
11.4.1 ¿Ü°úÀû Àý°³ »ý°Ë Open (Surgical) Biopsy
11.4.2 Àý°³ »ý°ËÀÇ ´ëü Substitution of Open Biopsies
11.4.3 ´Ù¸¥ Áø´ÜÀû ±â¹ýÀÇ ´ëü Substitution of Other Diagnostic Procedures
11.5 °æÇâ°ú ½Ã³ª¸®¿À Trends and Scenarios
11.6 ºñ¿ëÀÇ ºñ±³ Comparison of Costs
11.6.1 ºñ¿ë°ú Àý¾à Costs and Savings
11.7 ÀÇ»ç °áÁ¤ÀÚ´Â ¹Ù²î¾ú´Ù Decision Makers Have Changed
11.8 °á·Ð Conclusions
References
12 ÃÖ±Ù µ¥ÀÌÅÍÀÇ Ã¼°èÀû °ËÅä¿Í ¸ÞŸºÐ¼® Systematic Review and Meta-analysis of Recent Data
Renzo Brun del Re and Regula E.
12.1 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°ËÀÇ ÀÓ»óÀû ÀûÀý¼º¿¡ ´ëÇÑ Áõ°Å
Evidence for the Clinical Relevance of Minimally Invasive Breast Biopsy
12.1.1 °í¹®ÇåÀÇ Ã¼°èÀû °ËÅä Older Systematic Reviews
12.2 ¹®Çå Á¶»ç ¹æ¹ý Literature Search Methods
12.2.1 ¼öÇà¿¡ ´ëÇÑ Áõ°Å Evidence on Performance
12.2.2 À§Ç輺°ú ¾ÈÁ¤¼º¿¡ ´ëÇÑ ±Ù°Å Evidence on Risks and Safety
12.2.3 µ¥ÀÌÅÍÀÇ ¹ßÇ¥¿Í ºÐ¼® Presentation and Analysis of the Data
12.3 µ¥ÀÌÅÍÀÇ ¹ßÇ¥¿Í ºÐ¼® Presentation and Analysis of the Data
12.3.1 »ç¿ëµÈ Áõ°Å Evidence Used
12.3.2 °á°ú Results
12.4 MIBBÀÇ ¾ÈÁ¤¼º Safety of MIBB
12.4.1 Àý´ëÇ¥ÁØÀ¸·Î¼ÀÇ Àý°³»ý°Ë Open Biopsy as Gold Standard
12.4.2 14-G Á᫐ »ý°Ë°ú 11-G Áø°ø º¸Á¶ »ý°Ë 14-G Core Biopsies and 11 #NAME? Vacuum-Assisted Biopsies
12.4.3 MIBBÀÇ ¾ÈÁ¤¼º¿¡ ´ëÇÑ °á·Ð Conclusions on the Safety of MIBB
12.5 »îÀÇ Áú Quality of Life (HRQoL)
12.6 ¹ßÇ¥µÈ MIBB µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¿ä¾à°ú Åä·Ð Summary and Discussion of the MIBB Data Presented
12.7 °á·Ð Conclusions
References |
±³È¯ ¹× ȯºÒ °¡´É |
»óǰ¿¡ ¹®Á¦°¡ ÀÖÀ» °æ¿ì |
1) »óǰÀÌ Ç¥½Ã/±¤°íµÈ ³»¿ë°ú ´Ù¸£°Å³ª ºÒ·®(ºÎÆÐ, º¯Áú, ÆÄ¼Õ, Ç¥±â¿À·ù, À̹°È¥ÀÔ, Áß·®¹Ì´Þ)ÀÌ ¹ß»ýÇÑ °æ¿ì - ½Å¼±½Äǰ, ³ÃÀå½Äǰ, ³Ãµ¿½Äǰ : ¼ö·ÉÀÏ ´ÙÀ½³¯±îÁö ½Åû - ±âŸ »óǰ : ¼ö·ÉÀϷκÎÅÍ 30ÀÏ À̳», ±× »ç½ÇÀ» ¾È ³¯ ¶Ç´Â ¾Ë ¼ö ÀÖ¾ú´ø ³¯·ÎºÎÅÍ 30ÀÏ À̳» ½Åû 2) ±³È¯ ¹× ȯºÒ½Åû ½Ã ÆÇ¸ÅÀÚ´Â »óǰÀÇ »óŸ¦ È®ÀÎÇÒ ¼ö ÀÖ´Â »çÁøÀ» ¿äûÇÒ ¼ö ÀÖÀ¸¸ç »óǰÀÇ ¹®Á¦ Á¤µµ¿¡ µû¶ó Àç¹è¼Û, ÀϺÎȯºÒ, ÀüüȯºÒÀÌ ÁøÇàµË´Ï´Ù. ¹Ýǰ¿¡ µû¸¥ ºñ¿ëÀº ÆÇ¸ÅÀÚ ºÎ´ãÀ̸ç ȯºÒÀº ¹ÝǰµµÂøÀϷκÎÅÍ ¿µ¾÷ÀÏ ±âÁØ 3ÀÏ À̳»¿¡ ¿Ï·áµË´Ï´Ù. |
´Ü¼øº¯½É ¹× ÁÖ¹®Âø¿ÀÀÇ °æ¿ì |
1) ½Å¼±½Äǰ, ³ÃÀå½Äǰ, ³Ãµ¿½Äǰ ÀçÆÇ¸Å°¡ ¾î·Á¿î »óǰÀÇ Æ¯¼º»ó, ±³È¯ ¹× ȯºÒÀÌ ¾î·Æ½À´Ï´Ù. 2) ÈÀåǰ ÇǺΠƮ·¯ºí ¹ß»ý ½Ã Àü¹®ÀÇ Áø´Ü¼ ¹× ¼Ò°ß¼¸¦ Á¦ÃâÇϽøé ȯºÒ °¡´ÉÇÕ´Ï´Ù. ÀÌ °æ¿ì Á¦¹Ýºñ¿ëÀº ¼ÒºñÀÚ ºÎ´ãÀ̸ç, ¹è¼Ûºñ´Â ÆÇ¸ÅÀÚ°¡ ºÎ´ãÇÕ´Ï´Ù. ÇØ´ç ÈÀåǰ°ú ÇǺΠƮ·¯ºí°úÀÇ »ó´çÇÑ Àΰú°ü°è°¡ ÀÎÁ¤µÇ´Â °æ¿ì ¶Ç´Â Áúȯġ·á ¸ñÀûÀÇ °æ¿ì¿¡´Â Áø´Ü¼ ¹ß±Þºñ¿ëÀ» ÆÇ¸ÅÀÚ°¡ ºÎ´ãÇÕ´Ï´Ù. 3) ±âŸ »óǰ ¼ö·ÉÀϷκÎÅÍ 7ÀÏ À̳» ½Åû, ¿Õº¹¹è¼Ûºñ´Â ¼ÒºñÀÚ ºÎ´ã 4) ¸ð´ÏÅÍ ÇØ»óµµÀÇ Â÷ÀÌ·Î »ö»óÀ̳ª À̹ÌÁö°¡ ´Ù¸¥ °æ¿ì ´Ü¼øº¯½É¿¡ ÀÇÇÑ ±³È¯ ¹× ȯºÒÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. |
|
±³È¯ ¹× ȯºÒ ºÒ°¡ |
1) ½Åû±âÇÑÀÌ Áö³ °æ¿ì 2) ¼ÒºñÀÚÀÇ °ú½Ç·Î ÀÎÇØ »óǰ ¹× ±¸¼ºÇ°ÀÇ Àüü ¶Ç´Â ÀϺΰ¡ ¾ø¾îÁö°Å³ª ÈѼÕ, ¿À¿°µÇ¾úÀ» °æ¿ì 3) °³ºÀÇÏ¿© ÀÌ¹Ì ¼·ÃëÇÏ¿´°Å³ª »ç¿ë(Âø¿ë ¹× ¼³Ä¡ Æ÷ÇÔ)ÇØ »óǰ ¹× ±¸¼ºÇ°ÀÇ °¡Ä¡°¡ ¼Õ»óµÈ °æ¿ì 4) ½Ã°£ÀÌ °æ°úÇÏ¿© »óǰÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì 5) »ó¼¼Á¤º¸ ¶Ç´Â »ç¿ë¼³¸í¼¿¡ ¾È³»µÈ ÁÖÀÇ»çÇ× ¹× º¸°ü¹æ¹ýÀ» ÁöŰÁö ¾ÊÀº °æ¿ì 6) »çÀü¿¹¾à ¶Ç´Â ÁÖ¹®Á¦ÀÛÀ¸·Î ÅëÇØ ¼ÒºñÀÚÀÇ ÁÖ¹®¿¡ µû¶ó °³º°ÀûÀ¸·Î »ý»êµÇ´Â »óǰÀÌ ÀÌ¹Ì Á¦ÀÛÁøÇàµÈ °æ¿ì 7) º¹Á¦°¡ °¡´ÉÇÑ »óǰ µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì 8) ¸À, Çâ, »ö µî ´Ü¼ø ±âÈ£Â÷ÀÌ¿¡ ÀÇÇÑ °æ¿ì |